UPDATED May 05, 2024
Big ticket companies showing a potential underpricing based on intrinsic value
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
AZN | UK£120.50 | 0.2% | 1.1% | UK£186.8b | UK£131.66 | PE37x | E16.5% | 2.1% | ||
GSK | UK£17.34 | 3.8% | 18.5% | UK£70.7b | UK£20.20 | PE15.8x | E11.9% | 3.3% | ||
HIK | UK£19.60 | 1.6% | 4.6% | UK£4.3b | UK£22.82 | PE28.7x | E18.0% | 2.9% | ||
HCM | UK£3.10 | 2.0% | 18.1% | UK£2.6b | UK£4.29 | PE32.9x | E17.5% | n/a | ||
INDV | UK£14.35 | -1.9% | -9.5% | UK£1.9b | UK£24.40 | PE487.4x | E34.7% | 0% |